News Channels

15 May 2018 Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies
14 May 2018 Lilly to Acquire AurKa Pharma
14 May 2018 Entasis Therapeutics Initiates Clinical Studies of the Oral Extended-Spectrum Beta-Lactamase Inhibitor ETX0282
14 May 2018 Concentric Analgesics Announces Positive Topline Results from Phase 1b Clinical Trial for CA-008 in Post-Surgical Pain
14 May 2018 Alkahest Announces Initiation of Two Phase 2 Clinical Trials of ALK4290 in Age-Related Macular Degeneration
14 May 2018 CStone announces first patient dosing with anti-PD-1 antibody CS1003 in Phase I study in Australia
14 May 2018 Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
14 May 2018 Investigators Dose First Patient in Phase 1 Study of Treos Bio’s PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
14 May 2018 ORYZON announces First Patients In ETHERAL: a Phase IIa clinical trial in Alzheimer’s Disease with ORY-2001
14 May 2018 Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine
14 May 2018 AFFiRiS Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using AFFITOPE® PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinson's Disease Patients
14 May 2018 Medigene significantly expands TCR alliance with bluebird bio in cancer immunotherapy
14 May 2018 Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars
12 May 2018 Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
11 May 2018 Recently Presented Preclinical Data Show Potential for ADXS-NEO as Anti-Cancer Immunotherapy Agent
11 May 2018 eFFECTOR Initiates Randomized Dosing in Phase 2 Checkpoint Combination Trial of eFT508 and Avelumab in Colorectal Cancer
11 May 2018 Arrowhead Pharmaceuticals Presents Preclinical Data on Expanding Cardiometabolic Pipeline
11 May 2018 FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome
11 May 2018 AstraZeneca provides update on GALATHEA Phase III trial for Fasenra in chronic obstructive pulmonary disease
10 May 2018 Aravive Biologics Achieves Proof-of-Mechanism for Novel GAS6-AXL Pathway Inhibitor, AVB-S6-500, in Ongoing Phase 1 Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up